腫瘤資訊系統市場規模、佔有率和成長分析（按應用、產品/服務、最終用戶和地區分類）—產業預測（2026-2033 年）

全球腫瘤資訊系統市場規模預計在 2024 年達到 77.8 億美元，從 2025 年的 83.9 億美元成長到 2033 年的 154.2 億美元，在預測期（2026-2033 年）內複合年成長率為 7.9%。

全球腫瘤資訊系統 (OIS) 市場正經歷顯著成長，這主要得益於醫療機構（包括醫院和研究實驗室）對高效能病患資料管理和治療最佳化日益成長的需求。政府對腫瘤研究投入的不斷增加，在這一市場擴張中發揮了關鍵作用。隨著醫療服務提供者尋求先進的 OIS 軟體解決方案，癌症治療產業的創新和技術發展勢頭強勁。在醫療保健領域大量資金籌措的推動下，這為領先的 OIS 開發商創造了豐厚的投資機會。此外，OIS 透過提供全面及時的患者資訊來提高治療效果，使臨床醫生能夠制定精準的治療方案，最終有助於提升整體醫療品質和患者預後。未來，對能夠簡化數據收集並支持臨床決策的治療計劃系統的需求預計也將持續成長。

全球腫瘤資訊系統市場促進因素

全球癌症發生率的不斷攀升，推動了對腫瘤資訊系統的巨大需求。癌症仍然是全球首要死因，因此迫切需要高效的解決方案來改善治療方案的製定、數據管理以及整體患者照護品質。腫瘤資訊系統在此背景下發揮關鍵作用，它能夠實現即時資訊共用，並提高治療過程的精準度。此外，藥物治療的進步也增強了這些系統的效用，有助於改善患者的治療效果。這種不斷變化的情況凸顯了將先進技術融入腫瘤實踐的重要性，以便更好地應對癌症治療中日益嚴峻的挑戰。

限制全球腫瘤資訊系統市場的因素

腫瘤資訊系統（OIS）廣泛應用面臨的主要挑戰之一是其部署和維護帶來的沉重經濟負擔。先進的OIS平台需要對基礎設施、軟體和培訓人員進行大量投資，這使得小規模的醫療機構，尤其是在中低收入地區，難以負擔。此外，持續的維護、軟體更新和網路安全措施成本進一步加劇了經濟負擔，限制了資源匱乏地區該市場的成長潛力。這些經濟限制阻礙了許多醫療機構有效利用先進的OIS技術。

全球腫瘤資訊系統市場趨勢

全球腫瘤資訊系統 (OIS) 市場正日益受到人工智慧 (AI) 整合的影響，以提高治療的精確度和營運效率。 AI 驅動的解決方案能夠分析大量資料集，發現模式並預測患者對治療的反應，從而最大限度地減少人為錯誤，加快決策速度，即使在複雜情況下也能如此。這一趨勢反映了腫瘤治療正朝著更個人化的方向發展，迫使各公司投資於 AI 增強功能，以實現產品差異化，並滿足對創新癌症治療解決方案日益成長的需求。隨著市場的演變，AI 在塑造腫瘤管理系統的未來方面正發揮著至關重要的作用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 專利分析

全球腫瘤資訊系統市場規模（依產品及服務分類）及複合年成長率（2026-2033 年）

• 軟體
  • 病患資訊系統
  • 輻射資訊系統
  • 腫瘤電子健康記錄（EHR）
  • 實驗室資訊系統
  • 化療資訊系統
  • 治療計劃系統
  • 臨床決策支援系統
  • 放射治療計劃系統
  • 近距離放射治療計劃系統
  • 治療管理系統與醫學影像分析系統
  • 人口健康管理
  • 臨床整合解決方案
  • 圖片存檔與通訊系統（PACS）與視覺導航（VNA）
  • 先進的可視化和圖像分析解決方案
  • 輻射劑量管理解決方案
• 專業服務
  • 諮詢/最佳化服務
  • 實施服務
  • 售後及維護服務

全球腫瘤資訊系統市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 放射腫瘤學
• 腫瘤內科
• 外科腫瘤學

全球腫瘤資訊系統市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診斷影像中心
• 消融和癌症治療中心
• 政府機構
• 研究設施

全球腫瘤資訊系統市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Elekta AB（Sweden）
• McKesson Corporation（United States）
• Siemens Healthineers（Germany）
• Epic Systems Corporation（United States）
• IBM Corporation（United States）
• Cerner Corporation（United States）
• Advanced Data Systems Corporation（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• AmerisourceBergen Corporation（United States）
• General Electric Company（United States）
• Accuray Incorporated（United States）
• Optum, Inc.（United States）
• Allscripts Healthcare Solutions, Inc.（United States）
• MICA Information Systems, Inc.（United States）
• CureMD Healthcare（United States）
• EndoSoft LLC（United States）
• RaySearch Laboratories AB（Sweden）
• Altos Solutions（United States）
• Flatiron Health（United States）
• Bogardus Medical Systems（United States）

結論與建議

Global Oncology Information Systems Market size was valued at USD 7.78 Billion in 2024 and is poised to grow from USD 8.39 Billion in 2025 to USD 15.42 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The Global Oncology Information Systems (OIS) market is experiencing significant growth driven by the rising demand for efficient patient data management and treatment optimization in healthcare settings, including hospitals and research labs. Increased government investment in oncology research plays a pivotal role in this market expansion. As healthcare providers seek advanced OIS software solutions, innovation and technology development in the cancer care industry are gaining momentum. This presents lucrative opportunities for investment in leading OIS developers, fueled by substantial funding in the healthcare sector. Furthermore, OIS enhances treatment effectiveness by ensuring timely delivery of comprehensive patient information, allowing clinicians to create precise treatment plans, thereby improving overall care quality and patient outcomes. The future will also see increased demand for medical planning systems that streamline data collection and assist in clinical decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Information Systems Market Segments Analysis

Global Oncology Information Systems Market is segmented by Product and Service, Application, End User and region. Based on Product and Service, the market is segmented into Software and Professional Services. Based on Application, the market is segmented into Radiation Oncology, Medical Oncology and Surgical Oncology. Based on End User, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions and Research Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Information Systems Market

The rising global incidence of cancer significantly propels the demand for oncology information systems. As cancer remains a leading cause of mortality worldwide, there is an urgent need for efficient solutions to enhance treatment planning, data management, and overall patient care. Oncology information systems play a crucial role in this landscape by enabling real-time information sharing, which enhances the precision of treatment processes. Furthermore, the effectiveness of these systems is amplified by advances in pharmaceutical treatments, contributing to improved patient outcomes. This evolving landscape underscores the importance of integrating advanced technologies into oncology practices to better address the growing challenges associated with cancer care.

Restraints in the Global Oncology Information Systems Market

A significant challenge hindering the widespread adoption of Oncology Information Systems (OIS) is the substantial financial burden associated with their implementation and upkeep. Advanced OIS platforms necessitate considerable investments in infrastructure, software, and trained personnel, making them unaffordable for smaller healthcare facilities, particularly in low- and middle-income regions. Additionally, the ongoing expenses related to maintenance, software updates, and cybersecurity measures further exacerbate the financial strain, limiting the growth potential of this market in areas with fewer resources. These economic constraints inhibit the ability of many healthcare providers to leverage advanced OIS technology effectively.

Market Trends of the Global Oncology Information Systems Market

The Global Oncology Information Systems (OIS) market is increasingly influenced by the integration of artificial intelligence (AI) to enhance treatment precision and operational efficiency. AI-driven solutions are capable of analyzing extensive datasets to uncover patterns and predict patient responses to therapies, thereby minimizing human error and expediting decision-making, even in complex scenarios. This trend reflects a shift towards more personalized oncology care, compelling companies to invest in AI-enhanced functionalities to differentiate their offerings and cater to the rising demand for innovative cancer treatment solutions. As the market evolves, AI's role is becoming pivotal in shaping the future of oncology management systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Oncology Information Systems Market Size by Product and Service & CAGR (2026-2033)

• Market Overview
• Software
  • Patient Information Systems
  • Radiology Information Systems
  • Oncology Electronic Medical Record (EHR)
  • Laboratory Information Systems
  • Chemotherapy Information System
  • Treatment Planning Systems
  • Clinical Decision Support Systems
  • Radiotherapy Treatment Planning Systems
  • Brachytherapy Treatment Planning Systems
  • Treatment Management Systems & Medical Image Analysis Systems
  • Population Health Management
  • Clinical Integration Solutions
  • Picture Archiving and Communication System (PACS) & VNA
  • Advanced Visualization & Image Analysis Solutions
  • Radiation Dose Management Solutions
• Professional Services
  • Consulting/Optimization Services
  • Implementation Services
  • Post-Sale and Maintenance Services

Global Oncology Information Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Global Oncology Information Systems Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Global Oncology Information Systems Market Size & CAGR (2026-2033)

• North America (Product and Service, Application, End User)
  • US
  • Canada
• Europe (Product and Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Data Systems Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICA Information Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureMD Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoSoft LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altos Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bogardus Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations